NL-OMON37877已完成不适用
Plasma anti Xa-levels in obese patients undergoing bariatric surgery and receiving low molecular weight heparins for thromboprophylaxis. - Anti-Xa levels in the obese.
Slotervaartziekenhuis0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •a. All patients who have undergone bariatric surgery (laparoscopic gastric banding, duodenal switch procedure, sleeve gastrectomy, gastric bypass) recently and who are receiving enoxaparin 40 mg twice daily as noted in the protocols of the hospital
- •b. Adults> 18 years old
- •c. Obtained informed consent
排除标准
- •Patients with at least one of the following criteria will be excluded:
- •a. enoxaparin dosage different from that specified in the protocol (40 mg twice daily)
- •b. receiving a thrombolytic agent
- •c. antithrombin III deficiency
- •d. renal insufficiency (estimated Glomerular Filtration Rate<30 ml/min)
研究者
相似试验
进行中（未招募）
不适用
rsodeoxycholic Acid in Morbidly Obese Patients Before Bariatric Surgery - UrsoObeseEUCTR2007-005531-28-SEHanns-Ulrich Marschall
招募中
不适用
Relevant Use of Factor Xa inhibitor in Patients with Non-Valvular Atrial Fibrillation (RESPIRE trial): a multicenter, prospective, non- interventional, observational studyKCT0005330Korea University Anam Hospital2,000
Unknown
4 期
Prophylaxis of Venous Thromboembolism After Bariatric SurgeryMorbid ObesityThromboembolismBypass ComplicationsNCT02295150Rijnstate Hospital50
尚未招募
不适用
ipidomics- and cytokine analyses in obese patients in Primary arthroplasty - outcome corrrelation and Evaluation of predictive markersThe effects of obesity on the outcome of patients with primary knee or hip joint total endoprosthesis are investigated.E66Z96.64Z96.65ObesityDRKS00013550SWI der BGU Tübingen100
已完成
早期 1 期
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based HeparinDeep Vein ThrombosisVenous ThromboembolismPulmonary EmbolismNCT03516656University of Utah20